Bullying Perpetration and Narcissistic Personality Traits across Adolescence: Joint Trajectories and Childhood Risk Factors

gan Farrell, Ann H., Vaillancourt, Tracy
Cyhoeddwyd yn Front Psychiatry (2020)

Flexibility and innovation in the FDA’s novel regulatory approval strategies for hematologic drugs

gan Farrell, Ann T., Goldberg, Kirsten B., Pazdur, Richard
Cyhoeddwyd yn Blood (2017)

Transient ischemic attacks: predictability of future ischemic stroke or transient ischemic attack events

gan Gupta, Harsh V, Farrell, Ann M, Mittal, Manoj K
Cyhoeddwyd 2014

Effects of daily iron supplementation in primary-school–aged children: systematic review and meta-analysis of randomized controlled trials

gan Low, Michael, Farrell, Ann, Biggs, Beverley-Ann, Pasricha, Sant-Rayn
Cyhoeddwyd 2013

Carbapenem Resistant Enterobacteriaceae and Endoscopy: An Evolving Threat

gan O'Horo, John C., Farrell, Ann, Sohail, M. Rizwan, Safdar, Nasia
Cyhoeddwyd yn Am J Infect Control (2016)

Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care

gan Bohra, Anuj, Worland, Thomas, Hui, Samuel, Terbah, Ryma, Farrell, Ann, Robertson, Marcus
Cyhoeddwyd yn World J Gastroenterol (2020)

The NOURISH randomised control trial: Positive feeding practices and food preferences in early childhood - a primary prevention program for childhood obesity

gan Daniels, Lynne A, Magarey, Anthea, Battistutta, Diana, Nicholson, Jan M, Farrell, Ann, Davidson, Geoffrey, Cleghorn, Geoffrey
Cyhoeddwyd 2009

Systematic Review with Meta-analysis: Recurrence of Crohn's disease after Total Colectomy with Permanent Ileostomy

gan Fumery, Mathurin, Dulai, Parambir S., Meirick, Paul, Farrell, Ann M., Ramamoorthy, Sonia, Sandborn, William J., Singh, Siddharth
Cyhoeddwyd yn Aliment Pharmacol Ther (2016)

FDA Approval Summary: Nivolumab for the Treatment of Relapsed or Progressive Classical Hodgkin Lymphoma

gan Kasamon, Yvette L., de Claro, R. Angelo, Wang, Yaping, Shen, Yuan Li, Farrell, Ann T., Pazdur, Richard
Cyhoeddwyd yn Oncologist (2017)

An appraisal of published usability evaluations of electronic health records via systematic review

gan Ellsworth, Marc A, Dziadzko, Mikhail, O'Horo, John C, Farrell, Ann M, Zhang, Jiajie, Herasevich, Vitaly
Cyhoeddwyd yn J Am Med Inform Assoc (2017)

Effects of Toxic Compounds in Montipora capitata on Exogenous and Endogenous Zooxanthellae Performance and Fertilization Success

gan Hagedorn, Mary, Farrell, Ann, Carter, Virginia, Zuchowicz, Nikolas, Johnston, Erika, Padilla-Gamiño, Jacqueline, Gunasekera, Sarath, Paul, Valerie
Cyhoeddwyd yn PLoS One (2015)

Survival of ethnic and racial minority patients with multiple myeloma treated with newer medications

gan Pulte, E. Dianne, Nie, Lei, Gormley, Nicole, Goldberg, Kirsten B., McKee, Amy, Farrell, Ann, Pazdur, Richard
Cyhoeddwyd yn Blood Adv (2018)

FDA Approval Summary: Lenalidomide as Maintenance Therapy After Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma

gan Pulte, Elizabeth Dianne, Dmytrijuk, Andrew, Nie, Lei, Goldberg, Kirsten B., McKee, Amy E., Farrell, Ann T., Pazdur, Richard
Cyhoeddwyd yn Oncologist (2018)

FDA Approval Summary: Temsirolimus as Treatment for Advanced Renal Cell Carcinoma

gan Kwitkowski, Virginia E., Prowell, Tatiana M., Ibrahim, Amna, Farrell, Ann T., Justice, Robert, Mitchell, Shan Sun, Sridhara, Rajeshwari, Pazdur, Richard
Cyhoeddwyd 2010

In Reply

gan Kwitkowski, Virginia E., Prowell, Tatiana M., Ibrahim, Amna, Farrell, Ann T., Justice, Robert, Sun Mitchell, Shan, Sridhara, Rajeshwari, Pazdur, Richard
Cyhoeddwyd 2010

FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33‐Positive Acute Myeloid Leukemia

gan Norsworthy, Kelly J., Ko, Chia‐Wen, Lee, Jee Eun, Liu, Jiang, John, Christy S., Przepiorka, Donna, Farrell, Ann T., Pazdur, Richard
Cyhoeddwyd yn Oncologist (2018)

U.S. Food and Drug Administration Benefit‐Risk Assessment of Nilotinib Treatment Discontinuation in Patients with Chronic Phase Chronic Myeloid Leukemia in a Sustained Molecular Re...

gan Pulte, E. Dianne, Wroblewski, Tanya, Bloomquist, Erik, Tang, Shenghui, Farrell, Ann, Deisseroth, Albert, McKee, Amy E., Pazdur, Richard
Cyhoeddwyd yn Oncologist (2019)

FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell‐Induced Severe or Life‐Threatening Cytokine Release Syndrome

gan Le, Robert Q., Li, Liang, Yuan, Weishi, Shord, Stacy S., Nie, Lei, Habtemariam, Bahru A., Przepiorka, Donna, Farrell, Ann T., Pazdur, Richard
Cyhoeddwyd yn Oncologist (2018)

FDA Supplemental Approval: Blinatumomab for Treatment of Relapsed and Refractory Precursor B‐Cell Acute Lymphoblastic Leukemia

gan Pulte, E. Dianne, Vallejo, Jonathon, Przepiorka, Donna, Nie, Lei, Farrell, Ann T., Goldberg, Kirsten B., McKee, Amy E., Pazdur, Richard
Cyhoeddwyd yn Oncologist (2018)

A Benefit-Risk Analysis Approach to Capture Regulatory Decision-Making: Multiple Myeloma

gan Raju, G.K., Gurumurthi, Karthik, Domike, Reuben, Kazandjian, Dickran, Landgren, Ola, Blumenthal, Gideon M., Farrell, Ann, Pazdur, Richard, Woodcock, Janet
Cyhoeddwyd yn Clin Pharmacol Ther (2017)